跳至主要内容
临床试验/ACTRN12609000924257
ACTRN12609000924257招募中3 期

In hospitalised children requiring maintenance intravenous therapy, does Plasmalyte148 with 5% dextrose compared to 0.45% sodium chloride with 5% dextrose result in less hyponatraemia?

Royal Children's Hospital0 个研究点目标入组 690 人开始时间: 2009年10月27日最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
690

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
3 Months 至 18 Years(—)
性别
All

入选标准

  • To be eligible for this study, each subject must be aged between 3 months and 18 years old, be a patient at the Royal Children's Hospital in Melbourne and be assessed by an independent clinician as requiring intravenous fluid therapy at a rate of at least 50% and up to 150% recommended maintenance.

排除标准

  • An initial plasma sodium level of <130 or >150. A known abnormality of antidiuretic hormone secretion. Diabetic ketoacidosis. Renal disease requiring dialysis. A known disorder causing excessive renal sodium excretion. Pre or postoperative neurosurgical or craniofacial patients, requiring opening of the cranial cavity. Oncology patients requiring protocol-determined chemotherapy hydration. Children with inborn errors of metabolism requiring protocol determined fluid therapy. Proven meningitis. Severe liver disease. Conditions where intravenous fluids are anticipated to be given for less than six hours.

研究者

相似试验